Remove Competition Remove Government Remove Prescription Remove Sales
article thumbnail

The debate on DTC marketing is going to heat up again

World of DTC Marketing

SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. 2wo: DTC marketing is one of the reasons prescription drugs cost so much. DTC ads raise awareness around health conditions.

Marketing 285
article thumbnail

Pharma is “big business” that uses excuses to keep prices high

World of DTC Marketing

Seventy-nine percent of Americans think the price of prescription drugs is “unreasonable,” according to a 2019 Kaiser Family Foundation poll , and about 9 in 10 say they support the idea of the government negotiating prices. sales of the 20 top-selling drugs worldwide totaled $101.1 Big Pharma’s chokehold around the U.S.

Pharma 241
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Entry-Level Pharma Sales: It's More Than Just a Job Search (Here's Why)

Contrarian Sales Techniques

Are your interest piqued by the words ‘pharmaceutical sales’? Let’s look at the exciting possibilities, essential skills, and valuable resources that can prepare you for success with the entry-level pharmaceutical sales. Internships: While less common than seeking full-time jobs, this could still be a possible intent.

Sales 52
article thumbnail

Pharma says VPAS clawback jeopardises UK sector

pharmaphorum

A pharma industry organisation has warned that record levels of revenue clawback from the UK government is threatening “footprint, R&D and manufacturing investments” in the country. billion (around $4 billion) in revenue to the government – 26.5% Returns have risen sharply from £0.6 billion in 2021 to £1.8

Pharma 69
article thumbnail

Two Key Questions About Payer Strategies in 2023

PM360

What other policy issues or potential changes by the government should companies be aware of? However, we expect drugs without strong therapeutic alternatives to have an advantage in negotiations, while drugs in highly competitive classes will be negotiating from a weaker position. Given the volume of 340B sales (13% of total U.S.

article thumbnail

Selling Effectively In Medical Sales With John Crowder

Evolve Your Success

In this episode, Samuel Adeyinka interviews John Crowder who covers how to sell effectively in medical sales. Tune in now and get medical sales-ready! — Watch the episode here Listen to the podcast here Selling Effectively In Medical Sales With John Crowder We have with us another special guest. I’m wonderful.

article thumbnail

Teva asks SCOTUS to overturn “skinny label” verdict on GSK drug

pharmaphorum

” “Given the importance of this issue to patients, payors (including the federal government), and prescription-drug competition, this court should grant review,” it adds. The post Teva asks SCOTUS to overturn “skinny label” verdict on GSK drug appeared first on.